Rifamail 600 Capsule contains Rifampicin 600mg, a potent antibiotic used primarily in the treatment of tuberculosis and other bacterial infections. It works by inhibiting bacterial RNA polymerase, thereby suppressing bacterial growth and controlling infection effectively.
Rifampicin is a first-line antitubercular agent, often used in combination with other anti-TB drugs to prevent resistance and ensure comprehensive therapy. Its broad-spectrum antibacterial action also makes it useful in certain staphylococcal infections and prophylaxis of meningococcal disease.
Clinically, Rifamail 600 Capsule is indicated for active and latent tuberculosis, including pulmonary and extrapulmonary TB. The capsule formulation ensures accurate dosing, high bioavailability, and convenient administration, making it suitable for adult patients under medical supervision.
Regular use as prescribed helps in eradicating Mycobacterium tuberculosis, preventing disease progression, and reducing transmission risk. Rifamail 600 Capsule remains a trusted choice in antitubercular therapy, providing efficacy, safety, and reliable outcomes in TB management.